GHRP-2 vs Hexarelin: Head-to-Head Comparison
Both are potent GHRPs, with hexarelin producing the highest GH release of any peptide in this class. However, hexarelin causes rapid receptor desensitization, making it unsuitable for long-term use. GHRP-2 offers strong GH release with better sustainability over time.
Side-by-Side Comparison
| Dimension | GHRP-2 | Hexarelin |
|---|---|---|
| Evidence Level | Extensive clinical data | Extensive clinical data, cardioprotective studies |
| FDA Status | Not approved | Not approved |
| GH Release Potency | Strong | Strongest of all GHRPs |
| Desensitization Risk | Moderate; sustainable with cycling | High; significant desensitization within weeks |
| Cortisol/Prolactin Impact | Moderate elevation | Significant elevation of both |
| Unique Benefits | Balanced potency and tolerability | Cardioprotective effects, studied in heart failure |
| Long-Term Viability | Suitable with cycling protocols | Best used short-term or intermittently |
Peptide Overviews
GHRP-2
BHuman StudiesGHRP-2 is a synthetic hexapeptide growth hormone secretagogue. It is one of the most potent GHRPs and has been used in clinical research for GH deficiency diagnosis.
Hexarelin
BHuman StudiesHexarelin is one of the most potent synthetic GH secretagogues. Research also suggests it has direct cardioprotective effects independent of its GH-releasing properties.
GHRP-2 vs Hexarelin: FAQ
Stay Informed on Peptide Research
Get weekly comparison updates, new study alerts, and regulatory changes.
No spam. Unsubscribe anytime.
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.